Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Choudhury · SciRah

Researcher profile · Semantic Scholar

N. Choudhury

Share profile

N. Choudhury — researcher profile on SciRah

h-index: 20
Works: 57
Citations: 1,383

Most-cited papers

β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
Jinhua Xu, J. Prosperi, N. Choudhury, O. Olopade +1 more
2015PLoS ONE181 citations Open access
Semantic Scholar
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations.
N. Choudhury, Alexa Campanile, T. Antic, K. Yap +6 more
2016Journal of Clinical Oncology166 citations Open access
Semantic Scholar
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer
Jessica J. Lin, N. Choudhury, S. Yoda, Viola W. Zhu +23 more
2021Clinical Cancer Research114 citations Open access
Semantic Scholar
Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
N. Choudhury, A. Marra, J. Sui, J. Flynn +15 more
2022Journal of Thoracic Oncology104 citations Open access
Semantic Scholar
Low T-cell Receptor Diversity, High Somatic Mutation Burden, and High Neoantigen Load as Predictors of Clinical Outcome in Muscle-invasive Bladder Cancer.
N. Choudhury, K. Kiyotani, K. Yap, Alexa Campanile +6 more
2016European Urology Focus78 citations Open access
Semantic Scholar
Clinical benefit from immunotherapy in patients with small cell lung cancer is associated with tumor capacity for antigen presentation
C. Rudin, D. Balli, W. Lai, A. Richards +9 more
2023Journal of Thoracic Oncology77 citations Open access
Semantic Scholar
Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions
N. Choudhury, A. Schoenfeld, J. Flynn, C. Falcon +8 more
2021Clinical Cancer Research57 citations Open access
Semantic Scholar
Practical management of adverse events in patients receiving tarlatamab, a delta‐like ligand 3–targeted bispecific T‐cell engager immunotherapy, for previously treated small cell lung cancer
Jacob M. Sands, S. Champiat, Horst-Dieter Hummel, Kelly Garneski Paulson +15 more
2024medRxiv50 citations Open access
Semantic Scholar
APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas
P. Selenica, A. Marra, N. Choudhury, A. Gazzo +15 more
2022Annals of Oncology39 citations Open access
Semantic Scholar
Decade in review: a new era for RET-rearranged lung cancers
N. Choudhury, A. Drilon
2020Translational Lung Cancer Research38 citations Open access
Semantic Scholar
Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers
N. Choudhury, Jaime L. Schneider, T. Patil, Viola W. Zhu +14 more
2021JTO Clinical and Research Reports36 citations Open access
Semantic Scholar
Importance of immunopharmacogenomics in cancer treatment: Patient selection and monitoring for immune checkpoint antibodies
N. Choudhury, Yusuke Nakamura
2016Cancer Science32 citations Open access
Semantic Scholar
Establishment of CYP2D6 Reference Samples by Multiple Validated Genotyping Platforms
H. Fang, Xiao Liu, J. Ramírez, N. Choudhury +7 more
2014The Pharmacogenomics Journal32 citations Open access
Semantic Scholar
Updated results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engager in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine cancers (NEC).
H. Beltran, Melissa L. Johnson, Prantesh Jain, Erin L. Schenk +8 more
2024Journal of Clinical Oncology30 citations
Semantic Scholar
First-in-human imaging with [89Zr]Zr-DFO-SC16·56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate
S. Tendler, M. Dunphy, Matthew Agee, J. O'Donoghue +15 more
2024The Lancet Oncology30 citations Open access
Semantic Scholar
Interim results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engager, in patients (pts) with neuroendocrine prostate cancer (NEPC) and other neuroendocrine neoplasms (NEN).
H. Beltran, A. Dowlati, P. Jain, Melissa L. Johnson +9 more
2024Journal of Clinical Oncology28 citations
Semantic Scholar
A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer
N. Choudhury, W. Lai, A. Makhnin, G. Heller +14 more
2024Clinical Cancer Research26 citations
Semantic Scholar
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6–Targeting Antibody–Drug Conjugate, in Patients with Small Cell Lung Cancer
D. Morgensztern, N. Ready, Melissa L. Johnson, Afshin Dowlati +24 more
2024Clinical Cancer Research26 citations Open access
Semantic Scholar
The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
N. Choudhury, J. Lavery, Samantha Brown, I. de Bruijn +24 more
2023Clinical Cancer Research24 citations Open access
Semantic Scholar
Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center
N. Choudhury, Mansooreh Eghtesad, Sabah Kadri, John Cursio +4 more
2019OncoTarget20 citations Open access
Semantic Scholar
First-in-human study of ABBV-706, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors.
S. Chandana, N. Choudhury, Afshin Dowlati, Anne C. Chiang +14 more
2024Journal of Clinical Oncology19 citations
Semantic Scholar
Bioinformatically-expanded next-generation sequencing analysis optimizes identification of therapeutically relevant MET copy number alterations in >50,000 tumors
James P. Solomon, Soo-Ryum Yang, N. Choudhury, R. Ptashkin +11 more
2022Clinical Cancer Research19 citations Open access
Semantic Scholar
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
Hong-Tao Liu, Y. Zha, N. Choudhury, G. Malnassy +9 more
2018Experimental Hematology & Oncology19 citations Open access
Semantic Scholar
First-in-human study of ABBV-011, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate, in patients with small cell lung cancer.
D. Morgensztern, N. Ready, M. Johnson, A. Dowlati +16 more
2023Journal of Clinical Oncology18 citations Open access
Semantic Scholar
A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease.
H. Yu, Monica F. Chen, Angela B. Hui, N. Choudhury +16 more
2024Journal of Clinical Oncology16 citations
Semantic Scholar
Pilot Study of Dacomitinib for Patients With Metastatic EGFR-Mutant Lung Cancers With Disease Progression After Initial Treatment With Osimertinib
N. Choudhury, A. Makhnin, Y. Tobi, R. Daly +8 more
2021JCO Precision Oncology14 citations Open access
Semantic Scholar
Mechanisms of acquired resistance to TRK inhibitors.
Guilherme Harada, N. Choudhury, A. Schram, E. Rosen +14 more
2022Journal of Clinical Oncology13 citations
Semantic Scholar
Multidimensional Analysis of B7 Homolog 3 RNA Expression in Small Cell Lung Cancer Molecular Subtypes
C. Gay, T. Owonikoko, L. Byers, N. Choudhury +8 more
2025Clinical Cancer Research12 citations Open access
Semantic Scholar
Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers.
H. Hubbeling, N. Choudhury, C. Falcon, V. Rusch +10 more
2021International Journal of Radiation Oncology, Biology, Physics12 citations
Semantic Scholar
Lorlatinib and Bevacizumab Activity in ALK-Rearranged Lung Cancers After Lorlatinib Progression.
N. Choudhury, R. Young, M. Sellitti, Alexandra M. Miller +1 more
2020JCO Precision Oncology10 citations Open access
Semantic Scholar
Early dynamics of circulating tumor HPV-DNA with neoadjuvant chemotherapy and response-adapted de-escalation in human papillomavirus-associated oropharyngeal cancer
Ari J. Rosenberg, E. Izumchenko, Aditya Juloori, R. Katipally +15 more
2025Clinical Cancer Research9 citations
Semantic Scholar
Multidimensional analysis of B7 homolog 3 (B7-H3) RNA expression in small-cell lung cancer (SCLC) molecular subtypes.
C. Gay, T. Owonikoko, L. Byers, N. Choudhury +8 more
2024Journal of Clinical Oncology8 citations Open access
Semantic Scholar
Training Oncologists in the Time of COVID‐19
N. Choudhury, A. Shoushtari
2020The Oncologist5 citations Open access
Semantic Scholar
First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate
S. Tendler, M. Dunphy, Matthew Agee, Joseph A. O'Donoghue +15 more
2024medRxiv4 citations Open access
Semantic Scholar
Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report
R. Thummalapalli, N. Choudhury, F. Ehrich, Tyler J. Beardslee +9 more
2023JTO Clinical and Research Reports4 citations Open access
Semantic Scholar
Serplulimab With Chemotherapy in Extensive-Stage SCLC.
N. Choudhury, Gregory Riely
2022Journal of the American Medical Association (JAMA)4 citations
Semantic Scholar
Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers.
H. Hubbeling, N. Choudhury, Jessica Flynn, Zhi-Gang Zhang +12 more
2022JCO Precision Oncology4 citations Open access
Semantic Scholar
ctDNA analysis of NTRK fusion and mechanisms of acquired resistance to TRK inhibitors.
K. Sivaprakasam, Guilherme Harada, N. Choudhury, Casey Savin +3 more
2023Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Association of HER2 and ErbB3 molecular alterations with afatinib sensitivity in platinum-refractory metastatic urothelial carcinoma (UC) in a phase II trial.
N. Choudhury, Alexa Campanile, J. Wade, T. Antic +3 more
20152 citations
Semantic Scholar
Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers.
N. Choudhury, Jaime L. Schneider, T. Patil, Viola W. Zhu +14 more
Journal of Clinical Oncology2 citations
Semantic Scholar
Genomic characterization of FGFR-altered solid tumors using a clinically annotated pan-cancer repository.
N. Choudhury, Guilherme Harada, Karissa A. Whiting, R. Shen +9 more
2023Journal of Clinical Oncology1 citations
Semantic Scholar
MYC amplification segment-size mutual exclusivity analysis with other oncogenic events in a pan-cancer sequencing cohort.
M. Repetto, A. Richards, Monica F. Chen, Ying-Jie Zhu +12 more
2023Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research
N. Choudhury, Gregory Riely, P. Sabbatini, M. Hellmann
2021Cancer Cell1 citations Open access
Semantic Scholar
Afatinib activity in platinum-refractory metastatic urothelial carcinoma (UC) patients with ErbB alterations: Results of a phase II trial.
N. Choudhury, Alexa Campanile, T. Antic, J. Wade +3 more
20161 citations
Semantic Scholar
Abstract 4899: Tumor T-cell receptor (TCR) diversity elucidates the immune response to genetic alterations of muscle-invasive bladder cancer
N. Choudhury, K. Yap, K. Kiyotani, P. Yew +6 more
20151 citations
Semantic Scholar
T-cell engagers in small-cell lung cancer: current evidence and future directions – a position statement from the ETOP IBCSG Partners Foundation Workshop
May-Lucie Meyer, S. Peters, Myung-Ju Ahn, Isabelle Beuchat +31 more
2026Cancer Treatment Reviews0 citations
Semantic Scholar
Bridging EGFR/TGF-β signaling to bypass resistance to immune checkpoint blockade.
N. Choudhury, Aditi Kothari, C. Bestvina, Natalia Issaeva
2025Clinical Cancer Research0 citations
Semantic Scholar
Serial cfDNA sequencing in ROS1 fusion-positive lung cancers during treatment with entrectinib
N. Choudhury, Hyung Jun Woo, Monica F. Chen, Ronak H. Shah +3 more
2024JCO Precision Oncology0 citations Open access
Semantic Scholar
Clinical outcomes and genomic landscape of patients (pts) with EGFR-mutant lung cancer (EGFR+ LC) with central nervous system (CNS) metastases (mets).
J. Sui, Jessica A. Wilcox, S. Tischfield, N. Choudhury +4 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract 1394: Comprehensive clinical and genomic analysis for patients with MYC, MYCN, and MYCL amplified solid tumors
Monica F. Chen, A. Richards, Patrick Evans, Patrick Lee +14 more
2023Cancer Research0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Drilon×13
Invite
A. Drilon — researcher profile on SciRah
C. Falcon×10
Invite
C. Falcon — researcher profile on SciRah
C. Rudin×9
Invite
C. Rudin — researcher profile on SciRah
Gregory Riely×9
Invite
Gregory Riely — researcher profile on SciRah

Yusuke Nakamura

×8

Invite

Yusuke Nakamura — researcher profile on SciRah

Soo-Ryum Yang×8

Invite

Soo-Ryum Yang — researcher profile on SciRah

P. O'Donnell×6

Invite

P. O'Donnell — researcher profile on SciRah

Invite

N. Rekhtman — researcher profile on SciRah

Invite

M. Kris — researcher profile on SciRah

Alexa Campanile×5

Invite

Alexa Campanile — researcher profile on SciRah

Invite

T. Antic — researcher profile on SciRah

Invite

M. Berger — researcher profile on SciRah